Profilo
Liliana Bar worked as a Director of Development & Base Business Unit at OMRIX Biopharmaceuticals, Inc. She then worked as Vice President of Research & Development at Kamada Ltd.
from 2012 to 2019.
Dr. Bar received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Precedenti posizioni note di Liliana Bar
Società | Posizione | Fine |
---|---|---|
KAMADA LTD. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | - |
Formazione di Liliana Bar
The Hebrew University of Jerusalem | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
KAMADA LTD. | Health Technology |
Aziende private | 1 |
---|---|
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Liliana Bar